These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 8116044)

  • 1. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells.
    Watschinger B; Gallon L; Carpenter CB; Sayegh MH
    Transplantation; 1994 Feb; 57(4):572-6. PubMed ID: 8116044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts.
    Sayegh MH; Perico N; Imberti O; Hancock WW; Carpenter CB; Remuzzi G
    Transplantation; 1993 Aug; 56(2):461-5. PubMed ID: 7689263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
    Sayegh MH; Khoury SJ; Hancock WW; Weiner HL; Carpenter CB
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7762-6. PubMed ID: 1502196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
    Watschinger B
    Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation.
    Dalchau R; Fangmann J; Fabre JW
    Eur J Immunol; 1992 Mar; 22(3):669-77. PubMed ID: 1547813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell recognition of xeno-MHC peptides during concordant xenograft rejection.
    Murphy B; Auchincloss H; Carpenter CB; Sayegh MH
    Transplantation; 1996 Apr; 61(8):1133-7. PubMed ID: 8610405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel immunotherapeutic strategies using MHC derived peptides.
    Sayegh MH; Krensky AM
    Kidney Int Suppl; 1996 Jan; 53():S13-20. PubMed ID: 8770986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection.
    Waaga AM; Chandraker A; Spadafora-Ferreira M; Iyengar AR; Khoury SJ; Carpenter CB; Sayegh MH
    Transplantation; 1998 Apr; 65(7):876-83. PubMed ID: 9565089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents.
    Alfrey EJ; Wang X; Lee L; Holm B; Kim J; Adams G; Dafoe DC
    Transplantation; 1995 Apr; 59(8):1171-6. PubMed ID: 7732564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
    Sitaru AG; Timmermann W; Ulrichs K; Otto C
    Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo.
    Chen W; Murphy B; Waaga AM; Willett TA; Russell ME; Khoury SJ; Sayegh MH
    Transplantation; 1996 Sep; 62(6):705-10. PubMed ID: 8824464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
    Semiletova NV; Shen XD; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005 May; 37(4):1937-9. PubMed ID: 15919510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy.
    Womer KL; Stone JR; Murphy B; Chandraker A; Sayegh MH
    J Am Soc Nephrol; 2001 Nov; 12(11):2500-2506. PubMed ID: 11675428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.